EATG » R&D

R&D

Join the #TBontheList campaign

Global TB community demands inclusion of Mycobacterium tuberculosis in the WHO's Global priority list of antibiotic-resistant bacteria to guide research, discovery and development of new antibiotics. Join the Stop TB…

WHO publishes list of bacteria for which new antibiotics are urgently needed

27 February 2017 | GENEVA - WHO today published its first ever list of antibiotic-resistant "priority pathogens" – a catalogue of 12 families of bacteria that pose the greatest threat…

G-FINDER report 2016

A report on 2015 global investment into research and development (R&D) of new products for neglected diseases shows that year on year investment has decreased by $68 million (a reduction…

Medicines issued from EU-funded research should be widely accessible, groups say

Health advocacy groups called on the European Commission to change the way it funds research and development for new medicines so that innovations can serve a larger public. The call…

HIVACAR takes off to find cure for HIV

Hospital Clinic-IDIBAPS coordinates a European project to obtain a functional cure for HIV with immunotherapy The IDIBAPS and the Hospital Clínic of Barcelona lead a European project aimed at changing…

STEPS – HIV Cure Community Workshop in Glasgow – Final Report now out

On the 22nd of October, in Glasgow, the European AIDS Treatment Groups held the third edition of Steps – a community initiative to design the pathway to a long-term remission…

Community Cure Workshop Slides Now Online – Glasgow 2016

Organising the Community HIV Cure Workshop as a satellite event before the Glasgow HIV Drug Therapy Congress is a tradition already. This year's event, chaired by ECAB Chair Giulio Maria…

Petition to BRICS countries to triple funding for TB R&D

>200 petition BRICS countries to triple funding for TB R&D to improve TB/AIDS and AMR response. On 15 November 2016 over 200 petitioners from around the world asked Ministers of…

EPWG statement supporting recommendations of the UN High-Level Panel on Access to Medicines report

24 October 2016 We, Members of the European Parliament Working Group on innovation, access to medicines and poverty-related diseases (EPWG), would like to express our strong support for the findings…

Funding for TB research falls to lowest level in seven years

LIVERPOOL, UNITED KINGDOM, OCTOBER 25, 2016 —Tuberculosis (TB) killed 1.8 million people in 2015, making it the most deadly infectious disease worldwide, but funding for research into better TB prevention,…